| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00034983.1995.11812965 |
| P698 | PubMed publication ID | 7487223 |
| P50 | author | Hans-Peter Beck | Q37838937 |
| P2093 | author name string | T Smith | |
| N Gibson | |||
| B Genton | |||
| M P Alpers | |||
| F al-Yaman | |||
| S Mellor | |||
| J Hii | |||
| A Narara | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Papua New Guinea | Q691 |
| malaria | Q12156 | ||
| malaria vaccine | Q6741353 | ||
| P304 | page(s) | 359-376 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Annals of Tropical Medicine and Parasitology | Q22115494 |
| P1476 | title | The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity | |
| P478 | volume | 89 |
| Q41944114 | A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance |
| Q39473612 | Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity |
| Q44145302 | Area effects of bednet use in a malaria-endemic area in Papua New Guinea |
| Q44145286 | Associations of peak shifts in age--prevalence for human malarias with bednet coverage |
| Q34794075 | CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess. |
| Q37058594 | Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. |
| Q34781485 | Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans |
| Q91779426 | Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children |
| Q33530114 | Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children |
| Q33619827 | Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates |
| Q39473597 | Effect of insecticide-treated bed nets on the dynamics of multiple Plasmodium falciparum infections |
| Q46312010 | Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial |
| Q22010821 | Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea |
| Q36639790 | Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential for Plasmodium falciparum transmission |
| Q33948012 | Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America |
| Q39730124 | Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. |
| Q34286264 | Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea |
| Q37352530 | Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection |
| Q44151265 | Health research in Papua New Guinea |
| Q39491568 | Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea |
| Q36743853 | High levels of genetic diversity of Plasmodium falciparum populations in Papua New Guinea despite variable infection prevalence |
| Q37132076 | High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea |
| Q37058586 | High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea |
| Q56366851 | Histidine-Rich Protein 2 Gene Variation in a Malaria-Endemic Area of Papua New Guinea |
| Q46445624 | Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1). |
| Q35500954 | Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea |
| Q37058426 | Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea |
| Q37193274 | Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea |
| Q56342188 | Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax |
| Q35237540 | Modeling the effects of relapse in the transmission dynamics of malaria parasites. |
| Q44147632 | Mosquito nets for the elderly? |
| Q35637078 | Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea |
| Q34113806 | Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea |
| Q34004570 | Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. |
| Q40640727 | Naturally acquired cellular immune responses to the synthetic malarial peptide SPf66 in children in Papua New Guinea |
| Q33645352 | Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance |
| Q21032489 | Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites |
| Q33344896 | Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea |
| Q33535802 | Population hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity? |
| Q33713234 | Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. |
| Q37058815 | Red blood cell polymorphism and susceptibility to Plasmodium vivax |
| Q35690828 | Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes |
| Q35689218 | Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene |
| Q28483318 | Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study |
| Q46838126 | Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study |
| Q35649165 | Research challenges and gaps in malaria knowledge in Papua New Guinea |
| Q28469083 | Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trial |
| Q40551098 | Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children |
| Q44501476 | Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea |
| Q24803224 | Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea |
| Q35061598 | Strategies for detection of Plasmodium species gametocytes |
| Q35560038 | T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. |
| Q39071168 | The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea |
| Q35150329 | The epidemiology of malaria in Papua New Guinea |
| Q27344985 | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives |
| Q35150337 | The malaria vaccine development program in Papua New Guinea |
| Q37088901 | The risk of malarial infections and disease in Papua New Guinean children. |
| Q35579613 | The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area |
| Q37285841 | Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection |
| Q99569237 | Treatment and prevention of malaria in children |
| Q33749688 | Treatment with coartem (artemether-lumefantrine) in Papua New Guinea |
| Q33612282 | Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran |
| Q33384482 | Vivax malaria: a major cause of morbidity in early infancy |
| Q35868718 | Why do we need to know more about mixed Plasmodium species infections in humans? |
Search more.